432 related articles for article (PubMed ID: 3043792)
1. Cyclosporine-induced pseudo-graft-versus-host disease in the early post-cyclosporine period.
Beschorner WE; Shinn CA; Fischer AC; Santos GW; Hess AD
Transplantation; 1988 Aug; 46(2 Suppl):112S-117S. PubMed ID: 3043792
[TBL] [Abstract][Full Text] [Related]
2. Transfer of cyclosporine-associated syngeneic graft-versus-host disease by thymocytes. Resemblance to chronic graft-versus-host disease.
Beschorner WE; Hess AD; Shinn CA; Santos GW
Transplantation; 1988 Jan; 45(1):209-15. PubMed ID: 3257308
[TBL] [Abstract][Full Text] [Related]
3. Epithelial class II antigen expression in cutaneous graft-versus-host disease.
Beschorner WE; Farmer ER; Saral R; Stirling WL; Santos GW
Transplantation; 1987 Aug; 44(2):237-43. PubMed ID: 3307048
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens.
Hess AD; Horwitz LR; Laulis MK; Fuchs E
Clin Immunol Immunopathol; 1993 Dec; 69(3):341-50. PubMed ID: 7694818
[TBL] [Abstract][Full Text] [Related]
5. The thymus and prolonged administration of cyclosporine. Irreversible immunopathologic changes associated with autologous pseudo-graft-versus-host disease.
Shinozawa T; Beschorner WE; Hess AD
Transplantation; 1990 Jul; 50(1):106-11. PubMed ID: 2114678
[TBL] [Abstract][Full Text] [Related]
6. Mucosal cell-mediated immunological changes associated with experimental graft-versus-host disease.
Thomas DW; Matthews JB; Prime SS
J Oral Pathol Med; 1996 Apr; 25(4):145-50. PubMed ID: 8809681
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporine on T lymphocyte development. Relationship to syngeneic graft-versus-host disease.
Fischer AC; Laulis MK; Horwitz L; Hess AD
Transplantation; 1991 Jan; 51(1):252-9. PubMed ID: 1898996
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical changes in sigmoid colon after allogeneic and autologous bone marrow transplantation.
Forbes GM; Erber WN; Herrmann RP; Davies JM; Collins BJ
J Clin Pathol; 1995 Apr; 48(4):308-13. PubMed ID: 7615847
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine and the thymus: influence of irradiation and age on thymic immunopathology and recovery.
Beschorner WE; Di Gennaro KA; Hess AD; Santos GW
Cell Immunol; 1987 Dec; 110(2):350-64. PubMed ID: 3500795
[TBL] [Abstract][Full Text] [Related]
10. Immunohistology of skin and rectum biopsies in bone marrow transplant recipients.
Leskinen R; Taskinen E; Volin L; Ruutu T; Häyry P
APMIS; 1992 Dec; 100(12):1115-22. PubMed ID: 1492980
[TBL] [Abstract][Full Text] [Related]
11. Immunopathology of early graft-versus-host disease--a prospective study of skin, rectum, and peripheral blood in allogeneic and autologous bone marrow transplant recipients.
Sviland L; Pearson AD; Green MA; Baker BD; Eastham EJ; Reid MM; Hamilton PJ; Proctor SJ; Malcolm AJ
Transplantation; 1991 Dec; 52(6):1029-36. PubMed ID: 1836284
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous immunopathology of cyclosporin-A-induced autoimmunity in the rat.
Damoiseaux JG; Beijleveld LJ; van Breda Vriesman PJ
Clin Immunol Immunopathol; 1995 Dec; 77(3):315-23. PubMed ID: 7586742
[TBL] [Abstract][Full Text] [Related]
13. The immunopathology of upper gastrointestinal acute graft-versus-host disease. Lymphoid cells and endothelial adhesion molecules.
Roy J; Platt JL; Weisdorf DJ
Transplantation; 1993 Mar; 55(3):572-8. PubMed ID: 7681225
[TBL] [Abstract][Full Text] [Related]
14. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets.
Hess AD; Fischer AC; Beschorner WE
J Immunol; 1990 Jul; 145(2):526-33. PubMed ID: 1973185
[TBL] [Abstract][Full Text] [Related]
15. Cross-species graft-versus-host-disease is accompanied by a donor-derived cellular immune response.
Cooper MH; Nalesnik MA; Watkins SC; Hoffman RA; Ildstad ST
Transplantation; 1993 Oct; 56(4):934-40. PubMed ID: 8212220
[TBL] [Abstract][Full Text] [Related]
16. Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells.
Murphy GF; Whitaker D; Sprent J; Korngold R
Am J Pathol; 1991 Apr; 138(4):983-90. PubMed ID: 1901455
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of skin lesions in acute and chronic graft versus host disease following bone marrow transplantation.
Favre A; Cerri A; Bacigalupo A; Lanino E; Berti E; Grossi CE
Am J Surg Pathol; 1997 Jan; 21(1):23-34. PubMed ID: 8990138
[TBL] [Abstract][Full Text] [Related]
18. Promiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-versus-host disease: specificity of cytolytic effector T cells.
Hess AD; Thoburn C; Horwitz L
Transplantation; 1998 Mar; 65(6):785-92. PubMed ID: 9539089
[TBL] [Abstract][Full Text] [Related]
19. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
Truitt RL; Atasoylu AA
Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood.
Gruhn B; Häfer R; Kosmehl H; Fuchs D; Zintl F
Bone Marrow Transplant; 1998 May; 21(9):901-7. PubMed ID: 9613782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
